Skip to content
10-Q

Quarterly Report

NORTHWEST BIOTHERAPEUTICS INC NWBO

0001410578-25-001825

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 13, 2025 1.48B sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.44M sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.4M sh
Shares Diluted Q2 2025 · Jun 30, 2024 1.21M sh
Shares Diluted Q2 2025 · Jun 30, 2024 1.2M sh
Capex Q2 2025 · Jun 30, 2025 $397K
Capex Q2 2025 · Jun 30, 2024 $760K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$16.11M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$28.6M
Long Term Debt Q2 2025 · Jun 30, 2025 $64.74M
Long Term Debt Q2 2025 · Dec 31, 2024 $62.68M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $4.32M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $2.18M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$100.39M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$99.48M
Stockholders Equity Q2 2025 · Dec 31, 2024 −$94.49M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$76.5M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$73.28M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$65.77M
Current Liabilities Q2 2025 · Jun 30, 2025 $83.92M
Current Liabilities Q2 2025 · Dec 31, 2024 $68.27M
Total Liabilities Q2 2025 · Jun 30, 2025 $116.18M
Total Liabilities Q2 2025 · Dec 31, 2024 $105.71M
Current Assets Q2 2025 · Jun 30, 2025 $6.16M
Current Assets Q2 2025 · Dec 31, 2024 $4.06M
Total Assets Q2 2025 · Jun 30, 2025 $29.55M
Total Assets Q2 2025 · Dec 31, 2024 $26.73M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.01
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.03
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.02
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.03
Eps Basic Q2 2025 · Jun 30, 2025 −$0.01
Eps Basic Q2 2025 · Jun 30, 2025 −$0.03
Eps Basic Q2 2025 · Jun 30, 2024 −$0.02
Eps Basic Q2 2025 · Jun 30, 2024 −$0.03
Sga Expense Q2 2025 · Jun 30, 2025 $7.48M
Sga Expense Q2 2025 · Jun 30, 2025 $16.82M
Sga Expense Q2 2025 · Jun 30, 2024 $9.68M
Sga Expense Q2 2025 · Jun 30, 2024 $17.77M
Rd Expense Q2 2025 · Jun 30, 2025 $7.43M
Rd Expense Q2 2025 · Jun 30, 2025 $15.78M
Rd Expense Q2 2025 · Jun 30, 2024 $8.29M
Rd Expense Q2 2025 · Jun 30, 2024 $16.24M
Net Income Q2 2025 · Jun 30, 2025 −$15.38M
Net Income Q2 2025 · Jun 30, 2025 −$34.72M
Net Income Q2 2025 · Jun 30, 2024 −$17.87M
Net Income Q2 2025 · Jun 30, 2024 −$36.18M
Operating Income Q2 2025 · Jun 30, 2025 −$14.78M
Operating Income Q2 2025 · Jun 30, 2025 −$32.09M
Operating Income Q2 2025 · Jun 30, 2024 −$17.46M
Operating Income Q2 2025 · Jun 30, 2024 −$33.21M
Revenue Q2 2025 · Jun 30, 2025 $131K
Revenue Q2 2025 · Jun 30, 2025 $506K
Revenue Q2 2025 · Jun 30, 2024 $510K
Revenue Q2 2025 · Jun 30, 2024 $794K